Scientists will be able to detect cancer earlier from blood samples after advances were made in detecting microRNA molecules using gold-plated nanoparticles.
UNSW researchers have discovered a new way to detect ultralow levels of microRNA in a blood sample which could make diagnosis of cancer and other illnesses quicker and more efficient.
The research team used nanoparticles to latch on to the targeted microRNAs (miRNAs) which enabled them to be easily extracted. One of the main benefits was that it was effective even when the miRNA was in minuscule amounts in the blood sample. Previously, a much larger sample was needed to extract similar amounts.
MicroRNAs are short RNA molecules that target some messenger RNAs (genetic material used to synthesise proteins) to prevent them from coding for a specific protein. Impaired miRNA activity has been linked with the formation of cancerous tumours as well as metastasis, the spread of cancer to other parts of the body.
Scientia Professor Justin Gooding said the nanoparticles are, in effect, dispersible electrodes. When circulated through the blood they capture the miRNA before a magnet is used to recapture the nanoparticles with the newly attached microRNA.
“Now we get more of the microRNA because the dispersible electrodes capture nearly everything in the sample,” Professor Gooding said.
“Because the capture is so effective, we get higher sensitivities and can detect much lower limits.
“And since we bring them back to the electrode under a magnet, our response time is much faster.”
One of the advantages of being quicker is that it will cost less.
“It could be orders of magnitude cheaper. Our method takes 30 minutes compared with almost 12 hours for quantitative polymerase chain reaction,” Professor Gooding said.
Key to the new technology is not just the ability to detect lower concentrations of miRNA but the ability to detect a broad range of concentrations.
“This is really important to determine whether the levels of different microRNAs have increased or decreased,” Professor Gooding said.
“We can do this very quickly compared with the gold-standard nucleic acid amplification methods. And we can do it in unprocessed blood.
“What this means is the technology has the potential to determine the levels of microRNA just from a finger prick test.”
Professor Gooding said he would expect the technology to be available within three years, pending regulatory approvals.
The new diagnostic technique follows on the heels of a similar advance made by another UNSW research team exploring cancer detection in the blood.
In that study, published in Nature Communications, a team of medical researchers led by Professor Chris Heeschen developed a new way to detect early-stage cancer tumour cells in the blood using a malaria protein. This method, which targeted individual cancer cells found in a blood sample, also used a magnet to retrieve all the targeted cancer cells.
Professor Gooding believes the two methods, while working on very different scales, would be very complementary as tools to diagnose cancer.
“The malaria protein technology works by detecting cancer cells, rare cells in particular. These are found in the blood also and so are also compatible with the liquid biopsy concept,” he said.
“We are detecting small molecules found in the blood which could also identify the type of cancer, while they are looking for rare cells that are responsible for the spread of cancer. The two technologies could work very well together.”
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- Government board gives bad advice on cancer screeningson August 16, 2019 at 9:36 pm
Who are they? Patients with a family history of pancreatic cancer or a blood test indicating inherited risk. Screening means getting an annual MRI or endoscopic ultrasound of the pancreas. “If you ...
- Arundel farmers say their blood samples show high levels of ‘forever chemicals’on August 15, 2019 at 4:39 pm
“These blood test results add injury to insult ... A growing number of studies have linked PFAS – particularly two phased-out varieties, PFOA and PFOS — to cancer, thyroid disruption and other health ...
- Odds of blood cancer rise if family member has had iton August 9, 2019 at 8:09 am
He's a research fellow in genetics and epidemiology at the Institute of Cancer Research, in London. RELATED DNA blood test may help determine success of breast cancer treatment Efforts are underway to ...
- DNA blood test may help determine success of breast cancer treatmenton August 8, 2019 at 9:58 am
Could the DNA from a patient's breast tumor help doctors spot whether stray cancer cells are still in her blood? That's what a small, new study suggests is possible. If the findings are replicated in ...
- Personalised breast cancer test could tell when to stop treatmenton August 8, 2019 at 7:56 am
A personalised blood test can tell whether treatments for breast cancer are working, and possibly save people from unnecessary surgery, according to early results. If the test can be validated, it ...
- Promising Blood Test Could Help to Predict Breast Cancer Recurrenceon August 8, 2019 at 6:56 am
Doctors have gotten much better at detecting and treating breast cancer early. Drug and chemotherapy regimens to control tumors have gotten so effective, in fact, that in some cases, surgery is no ...
- New DNA Blood Test May Help Guide Breast Cancer Treatmenton August 8, 2019 at 6:39 am
New DNA Blood Test May Help Guide Breast Cancer Treatment By Serena Gordon HealthDay Reporter THURSDAY, Aug. 8, 2019 (HealthDay News) -- Could the DNA from a patient's breast tumor help doctors spot ...
- New breast cancer blood test 100 times more sensitive than similar testson August 7, 2019 at 9:22 pm
A novel blood test is hoped to help track the efficacy of early-stage drug treatments for breast cancer and avoid unnecessary surgical procedures(Credit: rbhavana/Depositphotos) An ...
- Highly sensitive blood test may help doctors tailor better breast cancer treatmentson August 7, 2019 at 8:50 pm
A new, highly sensitive blood test is one of the first to successfully monitor breast cancer patients with early stage disease and could be up to 100 times more sensitive than existing tests, ...
- New 'liquid biopsy' blood test improves breast cancer diagnosticson August 7, 2019 at 11:03 am
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational ...
via Bing News